Abstract
Introduction: The aim of the study was to perform the first meta-analysis for assessment of the pooled risk of malignancy of each category of the Sydney system for reporting of lymph nodal aspirates along with the evaluation of diagnostic accuracy. Methods: PubMed/MEDLINE and Embase were searched with the following keywords: “(Lymph node) AND (fine needle aspiration biopsy) OR (International system OR Sydney system)” in the timeframe 2020 to August 4, 2023. The selected articles were assessed for the risk of bias by the QUADAS-2 tool. The meta-analysis for sensitivity (SN) and specificity for each cut-off, that is, “atypical considered positive,” “suspicious of malignancy considered positive,” and “malignant considered positive” for the lesions, was carried out after excluding the inadequate samples in each study. To assess the diagnostic accuracy, summary receiver operating characteristic curves were constructed, and the diagnostic odds ratio was pooled in both scenarios. Results: Nine studies, all of which were retrospective cross-sectional studies, were evaluated with a total of 13,205 cases. The SN and specificity for the “atypical and higher risk categories” considered positive for malignancy were 97% (95% CI, 95–99%) and 96% (95% CI, 91–98%), respectively. The SN and specificity for the “suspicious of malignancy and higher risk categories” considered positive for malignancy were 91% (95% CI, 85–95%) and 99% (95% CI, 97–100%), respectively. The SN and specificity for the “malignant” considered positive for malignancy were 75% (95% CI, 65–84%) and 100% (95% CI, 99–100%), respectively. The pooled area under the curve was 99–100% for each of the cut-offs. Conclusion: This meta-analysis highlights the accuracy of the Sydney system in reporting lymph node aspirates. It exhibits the significance of the “suspicious” and “malignant” categories in diagnosing malignancy and of the “benign” category in excluding malignancy.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.